Skip to content

Encube Ethicals Ltd. IPO

Mainboard

Quick view

Announced: dates not out yet

What is this company? Encube Ethicals makes topical and transdermal medicines such as creams and patches.

  1. Apply

    Not yet

  2. AllotmentAllotment is the decision of who gets shares after the issue closes. Basis of allotment, in the glossary

    Not out yet

  3. Refund

    Not out yet

  4. Listing

    Not out yet

Finfod Research DeskUpdated 1 Nov 2026How we check

By Finfod Research Desk

On this page7 sections
  • Status

    Announced

  • Issue size

    ₹3,000 crore

Official links

  • Draft prospectusDRHP means the draft prospectus. It describes the company before the price and the dates are fixed.

How to apply

Use UPI and ASBA. The guide covers the close, allotment, and the T+3 listing.

Open the guide

Related guides

Encube Ethicals Ltd. IPO is announced. The issue size is ₹3,000 crore, with an offer for sale of ₹3,000 crore. In FY26, total income was ₹1,911.8 crore and profit after tax was ₹436.7 crore. Total income was up 39.6% from ₹1,369 crore in FY25. Profit after tax was up 75% from ₹249.6 crore in FY25.

Encube Ethicals Ltd. is at the draft prospectus stage. A DRHP is the draft red herring prospectus a company files before a public issue opens. It describes the business, the promoters, and how any fresh money would be used. It does not set the price band, the lot size, or the dates. Those are fixed later, in the red herring prospectus.

What to watch next for Encube Ethicals Ltd. is the opening date, the closing date, the price band, and the lot size. This page will list each figure only after it is announced. It will not guess a price, a date, or a grey market premium. Until those details are out, read the draft prospectus if this page links to it. Check who the promoters are and what the company says the money is for. When the dates are published, the timeline here will show the open, the close, allotment, refunds, the credit to your demat account, and the listing.

Encube Ethicals makes topical and transdermal medicines such as creams and patches. It supplies about 50 countries, including the US, the UK and Europe.

Dates

  1. Opens

    TBA

  2. Closes

    TBA

  3. AllotmentAllotment is the decision of who gets shares after the issue closes. Basis of allotment, in the glossary

    TBA

  4. Refunds

    TBA

  5. Demat credit

    TBA

  6. Listing

    TBA

Issue structure

Offer for sale

₹3,000 crore

Issue

Face value
₹1
Offer for saleOFS means offer for sale. Existing owners are selling shares. The company does not get that money.
₹3,000 crore
Exchanges
BSE, NSE
Registrar
MUFG Intime India Pvt. Ltd.

Financials

₹ crore, for the last three reported years.

Total income and profit

Each chart has its own scale. Amounts are in ₹ crore.

Total income

₹1,098 cr₹1,369 cr₹1,912 cr
FY24FY25FY26

Profit after tax

₹156 cr₹250 cr₹437 cr
FY24FY25FY26
Total income and profit after tax, in ₹ crore
YearTotal incomeProfit
FY24₹1,098.2 crore₹156.1 crore
FY25₹1,369 crore₹249.6 crore
FY26₹1,911.8 crore₹436.7 crore

Net worth

₹ crore, for each year that reports net worth.

Net worth. FY24, ₹1,258.4 crore. FY25, ₹1,512.8 crore. FY26, ₹1,953.6 crore.
FY24FY26
Net worth in ₹ crore
YearNet worth
FY24₹1,258.4 crore
FY25₹1,512.8 crore
FY26₹1,953.6 crore
YearTotal incomePATNet worthAssetsBorrowings
FY241,098.2156.11,258.4——
FY251,369249.61,512.8——
FY261,911.8436.71,953.6——

Frequently asked questions

What is the issue size?

The issue size is ₹3,000 crore.

Where is the DRHP?

The DRHP for Encube Ethicals Ltd. is linked on this page.

This page is a calendar of dates and prices. It is not a recommendation to apply.